Source:http://linkedlifedata.com/resource/pubmed/id/19207716
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
2009-5-20
|
pubmed:abstractText |
1. Our goal was to investigate the body distribution of serotonin (5-hydroxytryptamine; 5-HT) in rats infused with 5-HT (25 microg/kg per min) for 7 days and the contribution of the 5-HT transporter (SERT) for 5-HT uptake into the tissues. 2. Mini-osmotic pumps containing 5-HT or vehicle were implanted in rats knocked out for SERT (SERT-KO) or in wild-type (WT) rats. On the 8th day, tissues were harvested for measurements of 5-HT by high-performance liquid chromatography (HPLC). The 5-HT metabolite 5-hydroxyindole acetic acid (5-HIAA) was also measured by HPLC, because an increase in 5-HIAA in tissues from rats receiving 5-HT reflects 5-HT uptake followed by metabolism. 3. In WT rats infused with 5-HT, an increase in 5-HT or 5-HIAA was observed in the heart, pancreas, thyroid, adrenal gland, kidney, seminal vesicle, bladder, prostate, liver, oesophagus, stomach, femur, trachea, lung and spleen compared with vehicle-infused rats. An increase in 5-HT and 5-HIAA was not observed in aorta, vena cava and jejunum. In tissues from SERT-KO rats infused with 5-HT, the content of 5-HT or 5-HIAA was decreased in most of the tissues studied compared with 5-HT-infused WT rats. Although 5-HT uptake in the kidney, seminal vesicle, prostate, jejunum and trachea is SERT dependent, it is SERT independent in the pancreas. The remaining tissues display SERT-dependent and -independent mechanisms for 5-HT uptake. 4. Altogether, tissues from different systems, such as the cardiovascular, endocrine, genitourinary and gastrointestinal, accumulate 5-HT mainly via SERT and, thus, these systems are potential targets for drugs that interfere with 5-HT homeostasis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1440-1681
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
599-601
|
pubmed:meshHeading |
pubmed-meshheading:19207716-Animals,
pubmed-meshheading:19207716-Biological Availability,
pubmed-meshheading:19207716-Drug Evaluation, Preclinical,
pubmed-meshheading:19207716-Infusion Pumps,
pubmed-meshheading:19207716-Male,
pubmed-meshheading:19207716-Rats,
pubmed-meshheading:19207716-Rats, Transgenic,
pubmed-meshheading:19207716-Rats, Wistar,
pubmed-meshheading:19207716-Serotonin,
pubmed-meshheading:19207716-Serotonin Plasma Membrane Transport Proteins,
pubmed-meshheading:19207716-Tissue Distribution
|
pubmed:year |
2009
|
pubmed:articleTitle |
Body distribution of infused serotonin in rats.
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan 48824, USA. linderau@msu.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study
|